Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27525 (N-[3-(morpholin-4-yl)propyl]-8-oxo-9-azatetracyclo...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27528 (13-fluoro-N-[3-(morpholin-4-yl)propyl]-8-oxo-9-aza...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27521 (2-[4-(4-fluorophenyl)piperazin-1-yl]-N-{8-oxo-9-az...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 80 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27515 (14-amino-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]h...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 98 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27524 (1-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]h...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27522 (4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0....) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 105 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27520 (2-(dimethylamino)-N-{8-oxo-9-azatetracyclo[8.7.0.0...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 107 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27523 (2-hydroxy-N-{8-oxo-9-azatetracyclo[8.7.0.0^{2,7}.0...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 110 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27514 (13-amino-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]h...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27511 (14-nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]h...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 300 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27526 (N-[3-(1H-imidazol-1-yl)propyl]-8-oxo-9-azatetracyc...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 394 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27519 (4-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0....) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 400 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27529 (13-fluoro-N-(morpholin-4-yl)-8-oxo-9-azatetracyclo...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 450 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27530 (13-fluoro-14-(1H-imidazole-1-sulfonyl)-9-azatetrac...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27510 (13-nitro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]h...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27512 (13-fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27513 (14-fluoro-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 650 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27531 (indeno[1,2-c]isoquinolinone, 13 | sodium 8-oxo-9-a...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 700 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27516 (2-(dimethylamino)-N-{8-oxo-9-azatetracyclo[8.7.0.0...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 800 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27532 (4-methyl-4-[3-({8-oxo-9-azatetracyclo[8.7.0.0^{2,7...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 800 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27517 (2-(morpholin-4-yl)-N-{8-oxo-9-azatetracyclo[8.7.0....) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27518 (2-(4-methylpiperazin-1-yl)-N-{8-oxo-9-azatetracycl...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27527 (8-oxo-N-(3-phenylpropyl)-9-azatetracyclo[8.7.0.0^{...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27508 (9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM27506 (3-AB | 3-aminobenzamide | CHEMBL81977) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE MMDB PC cid PC sid PDB UniChem Patents | Article PubMed | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | 8.0 | 22 |
Inotek Pharmaceuticals Corporation | Assay Description The potency of inhibition on purified PARP enzyme was determined for selected compounds, and the potency was compared with that of 3-aminobenzamide (... | J Med Chem 48: 5100-3 (2005) Article DOI: 10.1021/jm0502891 BindingDB Entry DOI: 10.7270/Q2GF0RT9 | |||||||||||
More data for this Ligand-Target Pair |